Reviews
Qiang Jin, JingJing Wu, Yue Wu, Hongxin Li, Moshe Finel, Dandan Wang, Guangbo Ge. Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives[J]. Acta Pharmaceutica Sinica B, 2022, 12(3): 1068-1099

Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives
Qiang Jina, JingJing Wub, Yue Wua, Hongxin Lia, Moshe Finelc, Dandan Wanga, Guangbo Gea
a. Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;
b. Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China;
c. Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland
Abstract:
Drug-metabolizing enzymes (DMEs), a diverse group of enzymes responsible for the metabolic elimination of drugs and other xenobiotics, have been recognized as the critical determinants to drug safety and efficacy. Deciphering and understanding the key roles of individual DMEs in drug metabolism and toxicity, as well as characterizing the interactions of central DMEs with xenobiotics require reliable, practical and highly specific tools for sensing the activities of these enzymes in biological systems. In the last few decades, the scientists have developed a variety of optical substrates for sensing human DMEs, parts of them have been successfully used for studying target enzyme(s) in tissue preparations and living systems. Herein, molecular design principals and recent advances in the development and applications of optical substrates for human DMEs have been reviewed systematically. Furthermore, the challenges and future perspectives in this field are also highlighted. The presented information offers a group of practical approaches and imaging tools for sensing DMEs activities in complex biological systems, which strongly facilitates high-throughput screening the modulators of target DMEs and studies on drug/herb-drug interactions, as well as promotes the fundamental researches for exploring the relevance of DMEs to human diseases and drug treatment outcomes.
Key words:    Optical substrates    Drug-metabolizing enzymes (DMEs)    Fluorescence-based assay    High-throughput screening   
Received: 2021-08-03     Revised: 2021-10-06
DOI: 10.1016/j.apsb.2022.01.009
Funds: This work was supported by the NSF of China (81922070, 81973286, 82073813, 81803489), the National Key Research and Development Program of China (2017YFC1700200, 2017YFC1702000), the Three-year Action Plan of Shanghai TCM Development[ZY-(2018-2020)-CCCX-5001, China], Program of Shanghai Academic/Technology Research Leader (18XD1403600, China), Shuguang Program (18SG40, China) supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission, and Drug Innovation Major Project (2018ZX09731016, China).
Corresponding author: Dandan Wang,E-mai:wangdandan801@126.com;Guangbo Ge,E-mai:geguangbo@dicp.ac.cn     Email:wangdandan801@126.com;geguangbo@dicp.ac.cn
Author description:
Service
PDF(KB) Free
Print
0
Authors
Qiang Jin
JingJing Wu
Yue Wu
Hongxin Li
Moshe Finel
Dandan Wang
Guangbo Ge

References:
[1] Iyanagi T. Molecular mechanism of phase I and phase II drug-metabolizing enzymes:implications for detoxification. Int Rev Cytol 2007; 260:35-112
[2] Manikandan P, Nagini S. Cytochrome P450 structure, function and clinical significance:a review. Curr Drug Targets 2018; 19:38-54
[3] Zanger UM, Schwab M. Cytochrome p450 enzymes in drug metabolism:regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 2013; 138:103-141
[4] Munro AW, Girvan HM, Mason AE, Dunford AJ, McLean KJ. What makes a P450 tick?. Trends Biochem Sci 2013; 38:140-150
[5] Wang D, Zou L, Jin Q, Hou J, Ge G, Yang L. Human carboxylesterases:a comprehensive review. Acta Pharm Sin B 2018; 8:699-712
[6] Yiannakopoulou EC. Pharmacogenomics of phase II metabolizing enzymes and drug transporters:clinical implications. Pharmacogenomics J 2013; 13:105-109
[7] Court MH. Interindividual variability in hepatic drug glucuronidation:studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 2010; 42:209-224
[8] Achour B, Russell MR, Barber J, Rostami-Hodjegan A. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 2014; 42:500-510
[9] Lin JH, Lu AY. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev pharmacol Toxicol 2001; 41:535-567
[10] Sweeney BP, Bromilow J. Liver enzyme induction and inhibition:implications for anaesthesia. Anaesthesia 2006; 61:159-177
[11] Papasotiriou DG, Markoutsa S, Meyer B, Papadioti A, Karas M, Tsiotis G. Comparison of the membrane subproteomes during growth of a new pseudomonas strain on lysogeny broth medium, glucose, and phenol. J Proteome Res 2008; 7:4278-4288
[12] Hop CECA, Cole MJ, Davidson RE, Duignan DB, Federico J, Janiszewski JS, et al. High throughput adme screening:practical considerations, impact on the portfolio and enabler of in silico adme models. Curr Drug Metab 2008; 9:847-853
[13] Fallon JK, Harbourt DE, Maleki SH, Kessler FK, Ritter JK, Smith PC. Absolute quantification of human uridine-diphosphate glucuronosyl transferase (UGT) enzyme isoforms 1A1 and 1A6 by tandem LC-MS. Drug metab lett 2008; 2:210-222
[14] Coward JK, Wu FY. A continuous spectrophotometric assay for catechol-O-methyltransferase. Anal Biochem 1973; 55:406-410
[15] White RE. High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery. Annu Rev Pharmacol Toxicol 2000; 40:133-157
[16] Ung YT, Ong CE, Pan Y. Current high-throughput approaches of screening modulatory effects of xenobiotics on cytochrome P450 (CYP) enzymes. High Throughput 2018; 7:29
[17] Lv X, Xia Y, Finel M, Wu J, Ge G, Yang L. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharm Sin B 2019; 9:258-278
[18] Wu J, Guan X, Dai Z, He R, Ding X, Yang L, et al. Molecular probes for human cytochrome P450 enzymes:recent progress and future perspectives. Coordin Chem Rev 2021; 427:213600
[19] Feng L, Ning J, Tian X, Wang C, Zhang L, Ma X, et al. Fluorescent probes for bioactive detection and imaging of phase II metabolic enzymes. Coordin Chem Rev 2019; 399:213026
[20] Tian Z, Yan F, Tian X, Feng L, Cui J, Deng S, et al. A nir fluorescent probe for vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor. Acta Pharm Sin B 2021. Available from:https://doi.org/10.1016/j.apsb.2021.06.004
[21] Fuhr U, Hsin CH, Li X, Jabrane W, Sorgel F. Assessment of pharmacokinetic drug-drug interactions in humans:in vivo probe substrates for drug metabolism and drug transport revisited. Annu Rev Pharmacol Toxicol 2019; 59:507-536
[22] Tian Z, Ding L, Li K, Song Y, Dou T, Hou J, et al. Rational design of a long-wavelength fluorescent probe for highly selective sensing of carboxylesterase 1 in living systems. Anal Chem 2019; 91:5638-5645
[23] Jin Q, Feng L, Wang DD, Wu JJ, Hou J, Dai ZR, et al. A highly selective near-infrared fluorescent probe for carboxylesterase 2 and its bioimaging applications in living cells and animals. Biosens Bioelectron 2016; 83:193-199
[24] Jin Q, Feng L, Wang DD, Dai ZR, Wang P, Zou LW, et al. A two-photon ratiometric fluorescent probe for imaging carboxylesterase 2 in living cells and tissues. Acs Appl Mater Inter 2015; 7:28474-28481
[25] Singh D, Kashyap A, Pandey RV, Saini KS. Novel advances in cytochrome P450 research. Drug Discov Today 2011; 16:793-799
[26] Guengerich FP. Human cytochrome P450 enzymes. In:Ortiz de Montellano PR, editor. Cytochrome p450:structure, mechanism, and biochemistry. Boston:Springer; 2015. p. 523-785
[27] Li Y, Kang X, Yang G, Dai P, Chen C, Wang H. Identification of genetic polymorphisms of CYP2W1 in the three main chinese ethnicities:Han, tibetan, and uighur. Drug Metab Dispos 2016; 44:1510-1515
[28] Schneider E and Clark DS. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors. Biosens Bioelectron 2013; 39:1-13
[29] Wright AT, Song JD, Cravatt BF. A suite of activity-based probes for human cytochrome P450 enzymes. J Am Chem Soc 2009; 131:10692-10700
[30] Wright AT, Cravatt BF. Chemical proteomic probes for profiling cytochrome P450 activities and drug interactions in vivo. Chem Biol 2007; 14:1043-1051
[31] Sudsakorn S, Skell J, Williams DA, O'Shea TJ, Liu HL. Evaluation of 3-O-methylfluorescein as a selective fluorometric substrate for CYP2C19 in human liver microsomes. Drug Metab Dispos 2007; 35:841-847
[32] Dai ZR, Feng L, Jin Q, Cheng H, Li Y, Ning J, et al. A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme:CYP1A1 as a case study. Chem Sci 2017; 8:2795-2803
[33] Jin Q, Ma HY, Feng L, Wang P, He RJ, Ning J, et al. Sensing cytochrome P450 1A1 activity by a resorufin-based isoform-specific fluorescent probe. Chin Chem Lett 2020; 31:2945-2949
[34] Ghosal A, Hapangama N, Yuan Y, Lu XW, Horne D, Patrick JE, et al. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes. Biopharm Drug Dispos 2003; 24:375-384
[35] Ning J, Tian Z, Wang B, Ge G, An Y, Hou J, et al. A highly sensitive and selective two-photon fluorescent probe for real-time sensing of cytochrome P450 1A1 in living systems. Mater Chem Front 2018; 2:2013-2020
[36] Ning J, Wang W, Ge GB, Chu P, Long FD, Yang YL, et al. Target enzyme-activated two-photon fluorescent probes:a case study of CYP3A4 using a two-dimensional design strategy. Angew Chem Int Edit 2019; 58:9959-9963
[37] Renwick AB, Lewis DFV, Fulford S, Surry D, Williams B, Worboys PD, et al. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms:evidence for selectivity towards CYP3A4. Xenobiotica 2001; 31:187-204
[38] Spatzenegger M, Liu H, Wang QM, Debarber A, Koop DR, Halpert JR. Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J Pharmacol Exp Ther 2003; 304:477-487
[39] Feng L, Ning J, Tian X, Wang C, Yu Z, Huo X, et al. Fluorescent probes for the detection and imaging of cytochrome P450. Coordin Chem Rev 2021; 437:213740
[40] Zhou JJ, Zhong B, Silverman RB. Direct continuous fluorometric assay for monoamine oxidase B. Anal Biochem 1996; 234:9-12
[41] Chen G, Yee DJ, Gubernator NG, Sames D. Design of optical switches as metabolic indicators:new fluorogenic probes for monoamine oxidases (MAO A and B). J Am Chem Soc 2005; 127:4544-4545
[42] Albers AE, Rawls KA, Chang CJ. Activity-based fluorescent reporters for monoamine oxidases in living cells. Chem Commun (Camb) 2007; 28:4647-4649
[43] Aw J, Shao Q, Yang Y, Jiang T, Ang C, Xing B. Synthesis and characterization of 2-(2'-hydroxy-5'-chlorophenyl)-6-chloro-4(3H)-quinazolinone-based fluorogenic probes for cellular imaging of monoamine oxidases. Chem Asian J 2010; 5:1317-1321
[44] Zhang YX, Xu YF, Tan SY, Xu L, Qian XH. Rapid and sensitive fluorescent probes for monoamine oxidases B to a at low concentrations. Tetrahedron Lett 2012; 53:6881-6884
[45] Li X, Zhang H, Xie Y, Hu Y, Sun H, Zhu Q. Fluorescent probes for detecting monoamine oxidase activity and cell imaging. Org Biomol Chem 2014; 12:2033-2036
[46] Li LL, Li K, Liu YH, Xu HR, Yu XQ, Red emission fluorescent probes for visualization of monoamine oxidase in living cells. Sci Rep 2016; 6:31217
[47] Kim D, Sambasivan S, Nam H, Kim KH, Kim JY, Joo T, et al. Reaction-based two-photon probes for in vitro analysis and cellular imaging of monoamine oxidase activity. Chem Commun (Camb) 2012; 48:6833-6835
[48] Qin HH, Li LL, Li K, Yu XQ. Novel strategy of constructing fluorescent probe for MAO-b via cascade reaction and its application in imaging MAO-B in human astrocyte. Chin Chem Lett 2019; 30:71-74
[49] Li L, Zhang CW, Chen GY, Zhu B, Chai C, Xu QH, et al. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in parkinson's disease models. Nat Commun 2014; 5:3276
[50] Wang R, Han X, You J, Yu F, Chen L. Ratiometric near-infrared fluorescent probe for synergistic detection of monoamine oxidase b and its contribution to oxidative stress in cell and mice aging models. Anal Chem 2018; 90:4054-4061
[51] Long S, Chen L, Xiang Y, Song M, Zheng Y, Zhu Q. An activity-based fluorogenic probe for sensitive and selective monoamine oxidase-B detection. Chem Commun 2012; 48:7164-7166
[52] Li X, Yu J, Zhu Q, Qian L, Li L, Zheng Y, et al. Visualization of monoamine oxidases in living cells using "turn-on" fluorescence resonance energy transfer probes. Analyst 2014; 139:6092-6095
[53] Wu X, Li L, Shi W, Gong Q, Li X, Ma H. Sensitive and selective ratiometric fluorescence probes for detection of intracellular endogenous monoamine oxidase a. Anal Chem 2016; 88:1440-1446
[54] Meng ZJ, Yang L, Yao CX, Li H, Fu Y, Wang KX, et al. Development of a naphthlimide-based fluorescent probe for imaging monoamine oxidase a in living cells and zebrafish. Dyes Pigments 2020; 176:108208
[55] Wu X, Shi W, Li X, Ma H. A strategy for specific fluorescence imaging of monoamine oxidase a in living cells. Angew Chem Int Ed Engl 2017; 56:15319-15323
[56] Yang Z, Li W, Chen H, Mo Q, Li J, Zhao S, et al. Inhibitor structure-guided design and synthesis of near-infrared fluorescent probes for monoamine oxidase a (MAO-A) and its application in living cells and in vivo. Chem Commun 2019; 55:2477-2480
[57] Kim WY, Won M, Salimi A, Sharma A, Lim JH, Kwon SH, et al. Monoamine oxidase-a targeting probe for prostate cancer imaging and inhibition of metastasis. Chem Commun 2019; 55:13267-13270
[58] Fang H, Zhang H, Li L, Ni Y, Shi R, Li Z, et al. Rational design of a two-photon fluorogenic probe for visualizing monoamine oxidase a activity in human glioma tissues. Angew Chem Int Edit 2020; 59:7536-7541
[59] Wierzchowski J, Wroczynski P, Interewicz E. Selective assay of the cytosolic forms of the aldehyde dehydrogenase in rat, with possible significance for the investigations of cyclophosphamide cytotoxicity. Acta Pol Pharm 1996; 53:203-208
[60] Wierzchowski J, Wroczynski P, Laszuk K, Interewicz E. Fluorimetric detection of aldehyde dehydrogenase activity in human blood, saliva, and organ biopsies and kinetic differentiation between class i and class iii isozymes. Anal Biochem 1997; 245:69-78
[61] Yagishita A, Ueno T, Esumi H, Saya H, Kaneko K, Tsuchihara K, et al. Development of highly selective fluorescent probe enabling flow-cytometric isolation of ALDH3A1-positive viable cells. Bioconjug Chem 2017; 28:302-306
[62] Minn I, Wang H, Mease RC, Byun Y, Yang X, Wang J, et al. A red-shifted fluorescent substrate for aldehyde dehydrogenase. Nat Commun 2014; 5:3662
[63] Anorma C, Hedhli J, Bearrood TE, Pino NW, Gardner SH, Inaba H, et al. Surveillance of cancer stem cell plasticity using an isoform-selective fluorescent probe for aldehyde dehydrogenase 1A1. Acs Central Sci 2018; 4:1045-1055
[64] Bearrood TE, Aguirre-Figueroa G, Chan J. Rational design of a red fluorescent sensor for aldh1a1 displaying enhanced cellular uptake and reactivity. Bioconjug Chem 2020; 31:224-228
[65] Duellman SJ, Valley MP, Kotraiah V, Vidugiriene J, Zhou W, Bernad L, et al. A bioluminescence assay for aldehyde dehydrogenase activity. Anal Biochem 2013; 434:226-232
[66] Mendoza MF, Hollabaugh NM, Hettiarachchi SU, McCarley RL. Human NAD(P)H:quinone oxidoreductase type I (HNQO1) activation of quinone propionic acid trigger groups. Biochemistry 2012; 51:8014-8026
[67] Silvers WC, Payne AS, McCarley RL. Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye. Chem Commun (Camb) 2011; 47:11264-11266
[68] Best QA, Johnson AE, Prasai B, Rouillere A, McCarley RL. Environmentally robust rhodamine reporters for probe-based cellular detection of the cancer-linked oxidoreductase HNQO1. ACS Chem Biol 2016; 11:231-240
[69] Prasai B, Silvers WC, McCarley RL. Oxidoreductase-facilitated visualization and detection of human cancer cells. Anal Chem 2015; 87:6411-6418
[70] Park SY, Won M, Kang C, Kim JS, Lee MH. A coumarin-naphthalimide hybrid as a dual emissive fluorescent probe for HNQO1. Dyes Pigments 2019; 164:341-345
[71] Park SY, Jung E, Kim JS, Chi SG, Lee MH. Cancer-specific HNQO1-responsive biocompatible naphthalimides providing a rapid fluorescent turn-on with an enhanced enzyme affinity. Sensors (Basel) 2019; 20:53
[72] Pan D, Luo F, Liu X, Liu W, Chen W, Liu F, et al. A novel two-photon fluorescent probe with a long stokes shift and a high signal-to-background ratio for human NAD(P)H:quinone oxidoreductase 1 (HNQO1) detection and imaging in living cells and tissues. Analyst 2017; 142:2624-2630
[73] Kwon N, Cho MK, Park SJ, Kim D, Nam SJ, Cui L, et al. An efficient two-photon fluorescent probe for human NAD(P)H:quinone oxidoreductase (HNQO1) detection and imaging in tumor cells. Chem Commun (Camb) 2017; 53:525-528
[74] Cuff S, Lewis RD, Chinje E, Jaffar M, Knox R, Weeks I. An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells. Free Radic Biol Med 2018; 116:141-148
[75] Zhang C, Zhai BB, Peng T, Zhong Z, Xu L, Zhang QZ, et al. Design and synthesis of near-infrared fluorescence-enhancement probes for the cancer-specific enzyme HNQO1. Dyes Pigments 2017; 143:245-251
[76] Zheng Y, Pan D, Zhang Y, Zhang Y, Shen Y. Hemicyanine-based near-infrared fluorescent probe for the ultrasensitive detection of HNQO1 activity and discrimination of human cancer cells. Anal Chim Acta 2019; 1090:125-132
[77] Yang Q, Wen Y, Xu J, Shao S. An hbt-based fluorescent dye with enhanced quantum yield in water system and its application for constructing NQO1 fluorescent probe. Talanta 2020; 216:120982
[78] Zhu Y, Han JL, Zhang Q, Zhao Z, Wang J, Xu XW, et al. A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (HNQO1) detection and imaging in living tumor cells. Rsc Adv 2019; 9:26729-26733
[79] Punganuru SR, Madala HR, Arutla V, Zhang R, Srivenugopal KS. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging. Sci Rep 2019; 9:8577
[80] Yuan ZW, Xu MJ, Wu TZ, Zhang XY, Shen YZ, Ernest U, et al. Design and synthesis of nqo1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis. Talanta 2019; 198:323-329
[81] Qiao Z, Zhang H, Zhang Y, Wang K. Detection of lipase activity in cells by a fluorescent probe based on formation of self-assembled micelles. iScience 2020; 23:101294
[82] Shen Z, Prasai B, Nakamura Y, Kobayashi H, Jackson MS, McCarley RL. A near-infrared, wavelength-shiftable, turn-on fluorescent probe for the detection and imaging of cancer tumor cells. ACS Chem Biol 2017; 12:1121-1132
[83] Hettiarachchi SU, Prasai B, McCarley RL. Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore. J Am Chem Soc 2014; 136:7575-7578
[84] Fei Q, Zhou L, Wang F, Shi B, Li C, Wang R, et al. Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1. Dyes Pigments 2017; 136:846-851
[85] Dietze EC, Kuwano E, Hammock BD. Spectrophotometric substrates for cytosolic epoxide hydrolase. Anal Biochem 1994; 216:176-187
[86] Wixtrom RN, Hammock BD. Continuous spectrophotometric assays for cytosolic epoxide hydrolase. Anal Biochem 1988; 174:291-299
[87] Mateo C, Archelas A, Furstoss R. A spectrophotometric assay for measuring and detecting an epoxide hydrolase activity. Anal Biochem 2003; 314:135-141
[88] Mantovani SM, de Oliveira LG, Marsaioli AJ. Whole cell quick e for epoxide hydrolase screening using fluorescent probes. J Mol Catal B-Enzym 2008; 52-53:173-177
[89] Jones PD, Wolf NM, Morisseau C, Whetstone P, Hock B, Hammock BD. Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Anal Biochem 2005; 343:66-75
[90] Shen W, Zhang J, Mao G, Jiang K, Zhu Q. A long-wavelength, fluorogenic probe for epoxide hydrolase:7-(2-(oxiran-2-yl)ethoxy) resorufin. Biol Pharm Bull 2009; 32:1496-1499
[91] Morisseau C, Bernay M, Escaich A, Sanborn JR, Lango J, Hammock BD. Development of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studies. Anal Biochem 2011; 414:154-162
[92] Zhou QH, Qin WW, Finel M, He QQ, Tu DZ, Wang CR, et al. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors. Int J Biol Macromol 2021; 180:252-261
[93] Liang SC, Ge GB, Liu HX, Zhang YY, Wang LM, Zhang JW, et al. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin. Drug Metab Dispos 2010; 38:973-980
[94] Xia YL, Wang JJ, Li SY, Liu Y, Gonzalez FJ, Wang P, et al. Synthesis and structure-activity relationship of coumarins as potent MCL-1 inhibitors for cancer treatment. Bioorgan Med Chem 2021. Available from:https://doi.org/10.1016/j.bmc.2020.115851
[95] Xia Y, Lv X, He G, Dou T, Ge GB, Yang L. In vitro characterization of the glucuronidation pathways of D-luciferin mediated by huamn UDP-glucuronosyl-transferases. Drug Metab Pharmacok 2017; 32:S77
[96] Rahikainen T, Hakkinen MR, Finel M, Pasanen M, Juvonen RO. A high throughput assay for the glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin by recombinant human UDP-glucuronosyltransferases and liver microsomes. Xenobiotica 2013; 43:853-861
[97] Uchaipichat V, Mackenzie PI, Guo XH. Gardnerstephen D, Galetin A, Houston JB, et al. Human UDP-glucuronosyltransferases:isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 2004; 32:413-423
[98] Soikkeli A, Kurkela M, Hirvonen J, Yliperttula M, Finel M. Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6. Assay Drug Dev Technol 2011; 9:496-502
[99] Terai T, Tomiyasu R, Ota T, Ueno T, Komatsu T, Hanaoka K, et al. Tokyogreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1. Chem Commun 2013; 49:3101-3103
[100] Juvonen RO, Rauhamaki S, Kortet S, Niinivehmas S, Troberg J, Petsalo A, et al. Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10. Mol Pharmaceut 2018; 15:923-933
[101] Zhou QH, Lv X, Tian ZH, Finel M, Feng L, Huo PC, et al. A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors. Anal Chim Acta 2021; 1153:338305
[102] Lv X, Ge GB, Feng L, Troberg J, Hu LH, Hou J, et al. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications. Biosens Bioelectron 2015; 72:261-267
[103] Lv X, Feng L, Ai CZ, Hou J, Wang P, Zou LW, et al. A practical and high-affinity fluorescent probe for uridine diphosphate glucuronosyltransferase 1A1:a good surrogate for bilirubin. J Med Chem 2017; 60:9664-9675
[104] Kim B, Fukuda M, Lee JY, Su D, Sanu S, Silvin A, et al. Visualizing microglia with a fluorescence turn-on UGT1A7C substrate. Angew Chem Int Edit 2019; 58:7972-7976
[105] Zhu MY, Tian ZH, Jin LL, Huo XK, Wang C, Cui JN, et al. A highly selective fluorescent probe for real-time imaging of UDP-glucuronosyltransferase 1A8 in living cells and tissues. Front Chem Sci Eng 2019; 3:145-150
[106] Ma X, Tian X, Liu T, Ma Y, Gao J, Feng L, et al. Molecular-splicing strategy to construct a near-infrared fluorescent probe for UDP-glucuronosyltransferase 1A1. Angew Chem Int Edit 2021; 60:24566-24572
[107] Abdel-Latif AA. Reaction of catecholamines with hydroxylamine and its application to the assay of catechol O-methyl transferase. Anal Biochem 1969; 29:468-475
[108] Herblin WF. A simple colorimetric assay for catechol-O-methyl transferase. Anal Biochem 1973; 51:19-22
[109] Borchardt RT. A rapid spectrophotometric assay for catechol-O-methyltransferase. Anal Biochem 1974; 58:382-389
[110] Masuda M, Tsunoda M, Imai K. High-performance liquid chromatography-fluorescent assay of catechol-O-methyltransferase activity in rat brain. Anal Bioanal Chem 2003; 376:1069-1073
[111] Shoup RE, Davis GC, Kissinger PT. Determination of catechol-O-methyltransferase activity in various tissues by liquid chromatography. Anal Chem 1980; 52:483-487
[112] Zaitsu K, Okada Y, Nohta H, Kohashi K, Ohkura Y. Assay for catechol-O-methyltransferase by high-performance liquid chromatography with fluorescence detection. J Chromat A 1981; 211:129-136
[113] Nohta H, Noma S, Ohkura Y, Yoo BT. Assay for catechol-O-methyltransferase in erythrocytes using a new fluorogenic substrate, 2-(3,4-dihydroxyphenyl)naphtho[1,2-d]thiazole. J Chromatogr 1984; 308:93-100
[114] Smit NP, Pavel S, Kammeyer A, Westerhof W. Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem 1990; 190:286-291
[115] Qian XK, Wang P, Xia YL, Dou TY, Jin Q, Wang DD, et al. A highly selective fluorescent probe for sensing activities of catechol-O-methyltransferase in complex biological samples. Sensor Actuat B-Chem 2016; 231:615-623
[116] Wang P, Xia YL, Zou LW, Qian XK, Dou TY, Jin Q, et al. An optimized two-photon fluorescent probe for biological sensing and imaging of catechol-O-methyltransferase. Chemistry 2017; 23:10800-10807
[117] Lu LY, Hsu YC, Yang YS. Spectrofluorometric assay for monoamine-preferring phenol sulfotransferase (SULT1A3). Anal Biochem 2010; 404:241-243
[118] Chen WT, Liu MC, Yang YS. Fluorometric assay for alcohol sulfotransferase. Anal Biochem 2005; 339:54-60
[119] Reinen J, Vriese E, Glatt H, Vermeulen NP. Development and validation of a fluorescence hplc-based screening assay for inhibition of human estrogen sulfotransferase. Anal Biochem 2006; 357:85-92
[120] Baglia RA, Mills KR, Mitra K, Tutol JN, Ball D, Page KM, et al. An activity-based fluorescent sensor for the detection of the phenol sulfotransferase SULT1A1 in living cells. RSC Chem Biol 2021; 2:830-834
[121] Laurieri N, Crawford MH, Kawamura A, Westwood IM, Robinson J, Fletcher AM, et al. Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarker. J Am Chem Soc 2010; 132:3238-3239
[122] Egleton JE, Thinnes CC, Seden PT, Laurieri N, Lee SP, Hadavizadeh KS, et al. Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1. Bioorgan Med Chem 2014; 22:3030-3054
[123] Cui L, Zhong Y, Zhu W, Xu Y, Qian X. Selective and sensitive detection and quantification of arylamine N-acetyltransferase 2 by a ratiometric fluorescence probe. Chem Commun 2010; 46:7121-7123
[124] Wang X, Cui L, Zhou NN, Zhu WP, Wang R, Qian XH, et al. A highly selective and sensitive near-infrared fluorescence probe for arylamine N-acetyltransferase 2 in vitro and in vivo. Chem Sci 2013; 4:2936-2940
[125] Jin YZ, Tian ZH, Tian XG, Feng L, Cui JN, Ma XC. A highly selective fluorescent probe for real-time imaging of bacterial NAT2 and high-throughput screening of natural inhibitors for tuberculosis therapy. Mater Chem Front 2019; 3:145-150
[126] Terai T, Kikuchi K, Urano Y, Kojima H, Nagano T. A long-lived luminescent probe to sensitively detect arylamine N-acetyltransferase (NAT) activity of cells. Chem Commun (Camb) 2012; 48:2234-2246
[127] Fujikawa Y, Urano Y, Komatsu T, Hanaoka K, Kojima H, Terai T, et al. Design and synthesis of highly sensitive fluorogenic substrates for glutathione S-transferase and application for activity imaging in living cells. J Am Chem Soc 2008; 130:14533-14543
[128] He N, Bai S, Huang Y, Xing Y, Chen L, Yu F, et al. Evaluation of glutathione S-transferase inhibition effects on idiopathic pulmonary fibrosis therapy with a near-infrared fluorescent probe in cell and mice models. Anal Chem 2019; 91:5424-5432
[129] Tian Z, Tian X, Feng L, Tian Y, Huo X, Zhang B, et al. A highly sensitive and selective two-photon fluorescent probe for glutathione S-transferase detection and imaging in living cells and tissues. J Mater Chem B 2019; 7:4983-4989
[130] Mori M, Fujikawa Y, Kikkawa M, Shino M, Sawane M, Sato S, et al. A highly selective fluorogenic substrate for imaging glutathione S-transferase P1:development and cellular applicability in epigenetic studies. Chem Commun (Camb) 2019; 55:8122-8125
[131] Fujikawa Y, Terakado K, Nampo T, Mori M, Inoue H. 4-Bromo-1,8-naphthalimide derivatives as fluorogenic substrates for live cell imaging of glutathione S-transferase (GST) activity. Talanta 2019; 204:633-640
[132] Fujikawa Y, Morisaki F, Ogura A, Morohashi K, Enya S, Niwa R, et al. A practical fluorogenic substrate for high-throughput screening of glutathione S-transferase inhibitors. Chem Commun (Camb) 2015; 51:11459-11462
[133] Zhang J, Shibata A, Ito M, Shuto S, Ito Y, Mannervik B, et al. Synthesis and characterization of a series of highly fluorogenic substrates for glutathione transferases, a general strategy. J Am Chem Soc 2011; 133:14109
[134] Shibata A, Nakano Y, Ito M, Araki M, Zhang J, Yoshida Y, et al. Fluorogenic probes using 4-substituted-2-nitrobenzenesulfonyl derivatives as caging groups for the analysis of human glutathione transferase catalyzed reactions. Analyst 2013; 138:7326-7330
[135] Zhang J, Jin Z, Hu XX, Meng HM, Li J, Zhang XB, et al. Efficient two-photon fluorescent probe for glutathione S-transferase detection and imaging in drug-induced liver injury sample. Anal Chem 2017; 89:8097-8103
[136] Zhou W, Shultz JW, Murphy N, Hawkins EM, Bernad L, Good T, et al. Electrophilic aromatic substituted luciferins as bioluminescent probes for glutathione S-transferase assays. Chem Commun (Camb) 2006:4620-4622
[137] Ito M, Shibata A, Zhang J, Hiroshima M, Sako Y, Nakano Y, et al. Universal caging group for the in-cell detection of glutathione transferase applied to 19F NMR and bioluminogenic probes. Chem biochem 2012; 13:1428-1432
[138] Kong F, Pang X, Zhao J, Deng P, Zheng M, Zhong D, et al. Hydrolytic metabolism of cyanopyrrolidine DPP-4 inhibitors mediated by dipeptidyl peptidases. Drug Metab Dispos 2019; 47:238-248
[139] Asakura M, Fujii H, Atsuda K, Itoh T, Fujiwara R. Dipeptidyl peptidase-4 greatly contributes to the hydrolysis of vildagliptin in human liver. Drug Metab Dispos 2015; 43:477-484
[140] Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013; 500:227
[141] Marguet D, Baggio L, Kobayashi T, Bernard AM, Pierres M, Nielsen PF, et al. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A 2000; 97:6874-6879
[142] Morimoto C, Schlossman SF. The structure and function of CD26 in the T-cell immune response. Immunol Rev 1998; 161:55-70
[143] Takeda Y, Kume H, Takafuji K, Hirata H, Kijima T, Tomonaga T, et al. Proteomic profiling of peripheral exosomes leads to the identification of novel biomarker candidates for emphysema. Am J Resp Crit Care 2016; 193
[144] Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 2008; 31:1059-1062
[145] Lai KS, Ho NH, Cheng JD, Tung CH. Selective fluorescence probes for dipeptidyl peptidase activity-fibroblast activation protein and dipeptidyl peptidase IV. Bioconjugate Chem 2007; 18:1246-1250
[146] Wang Y, Wu X, Cheng Y, Zhao X. A fluorescent switchable AIE probe for selective imaging of dipeptidyl peptidase-4 in vitro and in vivo and its application in screening DPP-4 inhibitors. Chem Commun 2016; 52:3478-3481
[147] Gong Q, Shi W, Li L, Wu X, Ma H. Ultrasensitive fluorescent probes reveal an adverse action of dipeptide peptidase IV and fibroblast activation protein during proliferation of cancer cells. Anal Chem 2016; 88:8309-8314
[148] Zou LW, Wang P, Qian XK, Feng L, Yu Y, Wang DD, et al. A highly specific ratiometric two-photon fluorescent probe to detect dipeptidyl peptidase IV in plasma and living systems. Biosens Bioelectron 2017; 90:283-289
[149] Liu T, Ning J, Wang B, Dong B, Li S, Tian X, et al. Activatable near-infrared fluorescent probe for dipeptidyl peptidase IV and its bioimaging applications in living cells and animals. Anal Chem 2018; 90:3965-3973
[150] Xing J, Gong Q, Zhang R, Sun S, Zou R, Wu A. A novel non-enzymatic hydrolytic probe for dipeptidyl peptidase IV specific recognition and imaging. Chem Commun 2018; 54:8773-8776
[151] Ogasawara A, Kamiya M, Sakamoto K, Kuriki Y, Fujita K, Komatsu T, et al. Red fluorescence probe targeted to dipeptidylpeptidase-IV for highly sensitive detection of esophageal cancer. Bioconjugate Chem 2019; 30:1055-1060
[152] Ma H, Qian XK, Zhang J, Jin Q, Zou LW, Liu SQ, et al. Accurate and sensitive detection of dipeptidyl peptidase-IV activity by liquid chromatography with fluorescence detection. Anal Methods 2020; 12:848-854
[153] Dai ZR, Ge GB, Feng L, Ning J, Hu LH, Jin Q, et al. A highly selective ratiometric two-photon fluorescent probe for human cytochrome P450 1A. J Am Chem Soc 2015; 137:14488-14495
[154] Wang DD, Jin Q, Zou LW, Hou J, Lv X, Lei W, et al. A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples. Chem Commun 2016; 52:3183-3186
[155] Wang DD, Zou LW, Jin Q, Guan XQ, Yu Y, Zhu YD, et al. Bioluminescent sensor reveals that carboxylesterase 1A is a novel endoplasmic reticulum-derived serologic indicator for hepatocyte injury. ACS Sensors 2020; 5:1987-1995
[156] Ding L, Tian Z, Hou J, Dou T, Jin Q, Wang D, et al. Sensing carboxylesterase 1 in living systems by a practical and isoform-specific fluorescent probe. Chin Chem Lett 2019; 30:558-562
[157] Zou LW, Dou TY, Wang P, Lei W, Weng ZM, Hou J, et al. Structure-activity relationships of pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1. Front Pharmacol 2017; 8:435
[158] Lei W, Wang DD, Dou TY, Hou J, Feng L, Yin H, et al. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases. Toxicol Appl Pharm 2017; 321:48-56
[159] Liu YJ, Li SY, Hou J, Liu YF, Wang DD, Jiang YS, et al. Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in white mulberry root-bark. Fitoterapia 2016; 115:57-63
[160] Xue LJ, Qian XK, Jin Q, Zhu YD, Wang XY, Wang DD, et al. Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system. Anal Bioanal Chem 2020; 412:2645-2654
[161] Zhu YD, Guan XQ, Chen J, Peng S, Finel M, Zhao YY, et al. Neobavaisoflavone induces bilirubin metabolizing enzyme UGT1A1 via PPARα and PPARSγ. Front Pharmacol 2020; 11:628314
[162] Tian X, Yan F, Zheng J, Cui X, Feng L, Li S, et al. Endoplasmic reticulum targeting ratiometric fluorescent probe for carboxylesterase 2 detection in drug-induced acute liver injury. Anal Chem 2019; 91:15840-15845
[163] Hakamata W, Machida A, Oku T, Nishio T. Design and synthesis of an ER-specific fluorescent probe based on carboxylesterase activity with quinone methide cleavage process. Bioorg Med Chem Lett 2011; 21:3206-3209
[164] Zhang Y, Chen W, Feng D, Shi W, Li X, Ma H. A spectroscopic off-on probe for simple and sensitive detection of carboxylesterase activity and its application to cell imaging. Analyst 2012; 137:716-721
[165] Li D, Li Z, Chen W, Yang X. Imaging and detection of carboxylesterase in living cells and zebrafish pretreated with pesticides by a new near-infrared fluorescence off-on probe. J Agric Food Chem 2017; 65:4209-4215
[166] Wang J, Chen Q, Tian N, Zhu W, Zou H, Wang X, et al. A fast responsive, highly selective and light-up fluorescent probe for the two-photon imaging of carboxylesterase in living cells. J mater chem B 2018; 6:1595-1599
[167] Li M, Zhai C, Wang S, Huang W, Liu Y, Li Z. Detection of carboxylesterase by a novel hydrosoluble near-infrared fluorescence probe. Rsc Adv 2019; 9:40689-40693
[168] Zhou H, Tang J, Zhang J, Chen B, Kan J, Zhang W, et al. A red lysosome-targeted fluorescent probe for carboxylesterase detection and bioimaging. J Mater Chem B 2019; 7:2989-2996
[169] Jiang A, Chen G, Xu J, Liu YX, Zhao GH, Liu ZJ, et al. Ratiometric two-photon fluorescent probe for in situ imaging of carboxylesterase (CE)-mediated mitochondrial acidification during medication. Chem Commun 2019; 55:11358-11361
[170] Liu ZM, Feng L, Ge GB, Lv X, Hou J, Cao YF, et al. A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1. Biosens Bioelectron 2014; 57:30-35
[171] Feng L, Liu ZM, Xu L, Lv X, Ning J, Hou J, et al. A highly selective long-wavelength fluorescent probe for the detection of human carboxylesterase 2 and its biomedical applications. Chem Commu (Camb) 2014; 50:14519-14522
[172] Wang J, Williams ET, Bourgea J, Wong YN, Patten CJ. Characterization of recombinant human carboxylesterases:fluorescein diacetate as a probe substrate for human carboxylesterase 2. Drug Metab Dispos 2011; 39:1329-1333
[173] Liu Z, Feng L, Hou J, Lv X, Ning J, Ge G, et al. A ratiometric fluorescent sensor for highly selective detection of human carboxylesterase 2 and its application in living cells. Sensors Actuat B-Chem 2014; 205:151-157
[174] Feng L, Liu ZM, Hou J, Lv X, Ning J, Ge GB, et al. A highly selective fluorescent esipt probe for the detection of human carboxylesterase 2 and its biological applications. Biosens Bioelectron 2015; 65:9-15
[175] Kailass K, Sadovski O, Capello M, Kang Y, Fleming JB, Hanash SM, et al. Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor. Chem Sci 2019; 10:8428-8437
[176] Park SJ, Kim YJ, Kang JS, Kim IY, Choi KS, Kim HM. Carboxylesterase-2-selective two-photon ratiometric probe reveals decreased carboxylesterase-2 activity in breast cancer cells. Anal Chem 2018; 90:9465-9471
[177] Zhang X, Zhou Y, Gu X, Cheng Y, Hong M, Yan L, et al. Synthesis of a selective ratiometric fluorescent probe based on naphthalimide and its application in human cytochrome P450 1A. Talanta 2018; 186:413-420
[178] Ji H, Zhang X, Dai Y, Xue T, Misal S, Qi Z. A highly selective ratiometric fluorescent probe based on naphthalimide for detection and imaging of CYP1A1 in living cells and zebrafish. Analyst 2019; 144:7390-7397
[179] Xue T, Dai Y, Zhang X, Cheng Y, Gu X, Ji H, et al. Ultrasensitive near-infrared fluorescent probe with large stokes shift for real-time tracing of CYP1A1 in living cells and zebrafish model. Sensor Actuat B-chem 2019; 293:265-272
[180] Shimada T, Gillam EM, Sutter TR, Strickland PT, Guengerich FP, Yamazaki H. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 1997; 25:617-622
[181] Makings L, Zlokarnik G, inventors. Life Technologies Corp, assignee. Optical molecular sensors for cytochrome P450 activity. US006514687B1, 4 Feb 2003. Available from:https://patents.google.com/patent/US6514687B1/en
[182] Renwick AB, Surry D, Price RJ, Lake BG, Evans DC. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms. Xenobiotica 2000; 30:955-969
[183] Venhorst J, ter Laak AM, Commandeur JNM, Funae Y, Hiroi T, Vermeulen NPE. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem 2003; 46:74-86
[184] Marks BD, Smith RW, Braun HA, Goossens TA, Christenson M, Ozers MS, et al. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid P450 substrate. Assay Drug Dev Technol 2002; 1:73-81
[185] Ning J, Liu T, Dong P, Wang W, Ge G, Wang B, et al. Molecular design strategy to construct the near-infrared fluorescent probe for selectively sensing human cytochrome P450 2J2. J Am Chem Soc 2019; 141:1126-1134
[186] Dai Y, Xue T, Ji H, Zhang P, Zhang D, Qi Z. In situ target enzyme-activated near-infrared fluorescent probe:a case study of CYP2J2 using three-fragmentary molecular assembly engineering. Sensor Actuat B-Chem 2021; 328:129034
[187] Foti R, Wienkers L, Wahlstrom J. Application of cytochrome P450 drug interaction screening in drug discovery. High T Scr 2010; 13:145-158
[188] Cali JJ, Ma D, Wood MG, Meisenheimer PL, Klaubert DH. Bioluminescent assays for adme evaluation:dialing in CYP selectivity with luminogenic substrates. Expert opin drug met 2012; 8:1115-1130
[189] Promega Corporation. P450-GloTM assay technical bulletin. Available from:https://www.promega.com.cn/resources/protocols/technical-bulletins/101/p450-glo-assays-protocol/.
[190] Xiang YM, He BY, Li XF, Zhu Q. The design and synthesis of novel "turn-on" fluorescent probes to visualize monoamine oxidase-B in living cells. Rsc Adv 2013; 3:4876-4879
[191] Sun YP, Jung E, Kim JS, Chi SG, Min HLJS. Cancer-specific HNQO1-responsive biocompatible naphthalimides providing a rapid fluorescent turn-on with an enhanced enzyme affinity. Sensors 2019; 20:53
[192] Han J, Cheng L, Zhu Y, Xu X, Ge C. Covalent-assembly based fluorescent probes for detection of HNQO1 and imaging in living cells. Front Chem 2020; 8:756
[193] Zhu M, Tian Z, Jin L, Huo X, Wang C, Cui J, et al. A highly selective fluorescent probe for real-time imaging of UDP-glucuronosyltransferase 1A8 in living cells and tissues. Front Chem Sci Eng 2021. Available from:https://doi.org/10.1007/s11705-021-2064-8
[194] Alander J, Johansson K, Heuser VD, Farebo H, Jarvliden J, Abe H, et al. Characterization of a new fluorogenic substrate for microsomal glutathione transferase 1. Anal Biochem 2009; 390:52-56
[195] Song A, Shen X, Feng T, Gai S, Wei H, Li X, et al. Optimized fluorescent probe for specific imaging of glutathione S-transferases in living cells and mice. Chem Asian J 2020; 15:1464-1468
[196] Fujikawa Y, Nampo T, Mori M, Kikkawa M, Inoue H. Fluorescein diacetate (FDA) and its analogue as substrates for pi-class glutathione S-transferase (GSTP1) and their biological application. Talanta 2018; 179:845-852
[197] Tian X, Tian Z, Wang Y, Hou J, Feng L, Song L, et al. A highly selective fluorescent probe for detecting glutathione transferases to reveal anticancer-activity sensitivity of cisplatin in cancer cells and tumor tissues. Sensor Actuat B-Chem 2018; 277:423-430
[198] Song A, Feng T, Shen X, Gai S, Zhai Y, Chen H. Fluorescence detection of glutathione S-transferases in a low gsh level environment. Chem Commun (Camb) 2019; 55:7219-7222
[199] Kawaguchi M, Okabe T, Terai T, Hanaoka K, Kojima H, Minegishi I, et al. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening. Chemistry 2010; 16:13479-13486
[200] Guo X, Mu S, Li J, Zhang Y, Liu X, Zhang H, et al. Fabrication of a water-soluble near-infrared fluorescent probe for selective detection and imaging of dipeptidyl peptidase IV in biological systems. J Mater Chem B 2020; 8:767-775
Similar articles: